395 related articles for article (PubMed ID: 18380384)
1. [Guideline 'Renal cell carcinoma'].
Mulders PF; Brouwers AH; Hulsbergen-van der Kaa CA; van Lin EN; Osanto S; de Mulder PH
Ned Tijdschr Geneeskd; 2008 Feb; 152(7):376-80. PubMed ID: 18380384
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and molecular markers for renal cell carcinoma.
Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
[TBL] [Abstract][Full Text] [Related]
3. [The Dutch guideline 'Renal cell carcinoma'].
Osanto S; Bex A; Hulsbergen-van de Kaa CA; Soetekouw PM; Stemkens D
Ned Tijdschr Geneeskd; 2012; 156(5):A4462. PubMed ID: 22296904
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors for predicting the success of immunotherapy in metastatic renal cell carcinoma].
Schmitz-Dräger BJ; Jankevicius F; Otto T
Urologe A; 1995 May; 34(3):195-9. PubMed ID: 7610511
[TBL] [Abstract][Full Text] [Related]
5. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
[TBL] [Abstract][Full Text] [Related]
6. EORTC-GU group expert opinion on metastatic renal cell cancer.
de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma: current status and future prospects.
Drucker BJ
Cancer Treat Rev; 2005 Nov; 31(7):536-45. PubMed ID: 16236454
[TBL] [Abstract][Full Text] [Related]
9. [Renal cell carcinoma--a current review].
Schmid HP; Szabo J
Praxis (Bern 1994); 1997 May; 86(20):837-43. PubMed ID: 9312811
[TBL] [Abstract][Full Text] [Related]
10. No improvement in renal cell carcinoma survival: a population-based study in the Netherlands.
Aben KK; Luth TK; Janssen-Heijnen ML; Mulders PF; Kiemeney LA; van Spronsen DJ
Eur J Cancer; 2008 Aug; 44(12):1701-9. PubMed ID: 18502115
[TBL] [Abstract][Full Text] [Related]
11. [Localized and locally advanced renal cell carcinoma: method of outcome prognosis].
Serniak IuP
Urol Nefrol (Mosk); 1998; (1):32-5. PubMed ID: 9532944
[TBL] [Abstract][Full Text] [Related]
12. [New trends in the diagnosis and treatment of renal cell carcinoma].
Zisman A
Harefuah; 2002 Aug; 141(8):713-7, 761. PubMed ID: 12222136
[TBL] [Abstract][Full Text] [Related]
13. Multimodality treatment of metastatic renal cell carcinoma.
Mickisch GH
Expert Rev Anticancer Ther; 2002 Dec; 2(6):681-5. PubMed ID: 12503214
[TBL] [Abstract][Full Text] [Related]
14. [The practice guideline 'Carcinoma of the oral cavity and oropharynx'].
Knegt PP; Keus RB; Roodenburg JL
Ned Tijdschr Geneeskd; 2006 Jan; 150(2):83-8. PubMed ID: 16440562
[TBL] [Abstract][Full Text] [Related]
15. [Bellini renal cell carcinoma. Diagnosis and treatment].
Roupret M; Peyromaure M; Hupertan V; Larousserie F; Vieillefond A; Thiounn N; Dufour B; Zerbib M; Debre B; Mejean A
Prog Urol; 2004 Sep; 14(4):564-7. PubMed ID: 15776915
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
17. Collecting duct carcinoma of the kidney with retroperitoneal lymph mass.
Ortiz Gorraiz M; Rosales Leal JL; Tallada Buñuel M; Zilbermann Morales S
Arch Esp Urol; 2004 Mar; 57(2):179-82. PubMed ID: 15074793
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options in renal cell carcinoma.
Buzaid AC; Todd MB
Semin Oncol; 1989 Feb; 16(1 Suppl 1):12-9. PubMed ID: 2465574
[TBL] [Abstract][Full Text] [Related]
19. [Primary treatment of renal cell carcinoma. Yesterday, today, tomorrow].
Dufour B
Bull Acad Natl Med; 2009 Mar; 193(3):691-707; discussion 707-8. PubMed ID: 19883019
[TBL] [Abstract][Full Text] [Related]
20. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
